Product Information
METRONIDAZOLE TOPICAL 1% GEL is a generic product labeled by Aurobindo Pharma Limited, priced at $0.6210 per GM under NDC 59651081360. Its NADAC has been published 50 times since Oct 22, 2025.
FDA first approved this application on Oct 15, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/g
Manufacturer
Aurobindo Pharma LimitedNDC
59651081360
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA218941FDA Approved
10/15/2024
TE Code
AB
On Market Since
10/15/2024
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE TOPICAL 1% GEL has been published 50 times since Oct 22, 2025, and over the history we have for it it has declined 18.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6210 per GM |
|---|---|
| All-time high | $0.7658 (Nov 12, 2025) |
| All-time low | $0.6209 (Aug 19, 2026) |
| 52-week high | $0.7658 |
| 52-week low | $0.6209 |
| Median price | $0.6736 |
| Average price | $0.6797 |
| Largest weekly change | -5.4% (Dec 17, 2025) |
| Weeks tracked | 50 |
| Tracking since | Oct 22, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the METRONIDAZOLE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
METRONIDAZOLE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitroimidazole Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METRONIDAZOLE TOPICAL 1% GEL?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE TOPICAL 1% GEL, manufactured by Aurobindo Pharma Limited, is $0.6210 per GM (NDC 59651081360), effective Sep 30, 2026.
How has the price of METRONIDAZOLE TOPICAL 1% GEL changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE TOPICAL 1% GEL has declined 18.9%. It has been tracked across 50 weekly CMS publications since Oct 22, 2025.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE TOPICAL 1% GEL?
Since Oct 22, 2025, the NADAC for METRONIDAZOLE TOPICAL 1% GEL has ranged from a low of $0.6209 (Aug 19, 2026) to a high of $0.7658 (Nov 12, 2025), with a median of $0.6736 per GM.
Are there cheaper alternatives to METRONIDAZOLE TOPICAL 1% GEL?
No other NADAC-published product currently shares the active ingredient and strength of METRONIDAZOLE TOPICAL 1% GEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METRONIDAZOLE TOPICAL 1% GEL?
METRONIDAZOLE TOPICAL 1% GEL (NDC 59651081360) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.